Search Results - "EVANS, William K"

First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review by Goffin, John, Lacchetti, Christina, Ellis, Peter M, Ung, Yee C, Evans, William K

“…Non-small cell lung cancer (NSCLC) frequently presents at an incurable stage, and a majority of patients will be considered for palliative chemotherapy at some…”
Get more information

Physician-brief advice for promoting smoking cessation among cancer patients on treatment in low and middle-income countries: a scoping review by Ilesanmi, Olayinka Stephen, Faseru, Babalola, Afolabi, Aanuoluwapo Adeyimika, Odukoya, Olukemi, Ayo-Yusuf, Olalekan, Akinsolu, Folahanmi, Adebiyi, Akindele Olupelumi, Evans, William K

“…Physician-brief advice has been utilized in high-income countries to promote smoking cessation among cancer patients. Empirical evidence on its effectiveness…”
Get full text

The management of thymoma: a systematic review and practice guideline by Falkson, Conrad B, Bezjak, Andrea, Darling, Gail, Gregg, Richard, Malthaner, Richard, Maziak, Donna E, Yu, Edward, Smith, Christopher A, McNair, Sheila, Ung, Yee C, Evans, William K

“…Thymoma is a rare tumor for which there is little randomized evidence to guide treatment. Because of the lack of high-quality evidence, a formal…”
Get more information

Biennial lung cancer screening in Canada with smoking cessation—outcomes and cost-effectiveness by Goffin, John R., MD, FRCPC, Flanagan, William M., BM, Miller, Anthony B., MD, FRCPC, Fitzgerald, Natalie R., MA, Memon, Saima, MBBS, MPH, Wolfson, Michael C., PhD, Evans, William K., MD, FRCPC

“…Highlights • Lung cancer screening by CT decreases mortality but consumes resources. • Our model suggests that biennial screening is more cost-effective than…”
Get full text

Impact of smoking on health system costs among cancer patients in a retrospective cohort study in Ontario, Canada by Isaranuwatchai, Wanrudee, de Oliveira, Claire, Mittmann, Nicole, Evans, William K (Bill), Peter, Alice, Truscott, Rebecca, Chan, Kelvin KW

“…ObjectiveSmoking is the main modifiable cancer risk factor. The objective of this study was to examine the impact of smoking on health system costs among newly…”
Get full text

Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline by PISTERS, Katherine M. W, EVANS, William K, GASPAR, Laurie E, PASS, Harvey I, SPIGEL, David R, STRAWN, John R, UNG, Yee C, SHEPHERD, Frances A, AZZOLI, Christopher G, KRIS, Mark G, SMITH, Christopher A, DESCH, Christopher E, SOMERFIELD, Mark R, BROUWERS, Melissa C, DARLING, Gail, ELLIS, Peter M

“…To determine the role of adjuvant chemotherapy and radiation therapy in patients with completely resected stage IA-IIIA non-small-cell lung cancer (NSCLC). The…”
Get full text

Cost-effectiveness of Lung Cancer Screening in Canada by Goffin, John R, Flanagan, William M, Miller, Anthony B, Fitzgerald, Natalie R, Memon, Saima, Wolfson, Michael C, Evans, William K

“…The US National Lung Screening Trial supports screening for lung cancer among smokers using low-dose computed tomographic (LDCT) scans. The cost-effectiveness…”
Get more information

Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned by Evans, William K., Takhar, Pam, McDonald, Valerie, Elias, Martine, Binder, Louise, Michaud, Stéphanie, Tadrous, Mina, Muñoz, Caroline, Chan, Kelvin K. W.

“…The Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) Collaboration established the Engagement Working Group (WG) to ensure that all key…”
Get full text

Identifying Best Implementation Practices for Smoking Cessation in Complex Cancer Settings by Giannopoulos, Eleni, Papadakos, Janet, Cameron, Erin, Brual, Janette, Truscott, Rebecca, Evans, William K, Giuliani, Meredith Elana

“…In response to evidence about the health benefits of smoking cessation at time of cancer diagnosis, Ontario Health (Cancer Care Ontario) (OH-CCO) instructed…”
Get full text

Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated With New Cancer Drugs by BERRY, Scott R, BELL, Chaim M, UBEL, Peter A, EVANS, William K, NADLER, Eric, STREVEL, Elizabeth L, NEUMANN, Peter J

“…Oncologists in the United States and Canada work in different health care systems, but physicians in both countries face challenges posed by the rising costs…”
Get full text

Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise by Dai, Wei Fang, Craig, Erica, Fraser, Brent, Chambers, Alex, Mai, Helen, Brown, M Bryson, Earle, Craig C, Evans, William K, Geirnaert, Marc, Taylor, Marianne, Trudeau, Maureen, Sperber, Daniel, Beca, Jaclyn M, Denburg, Avram, Mercer, Rebecca E, Parmar, Ambica, Tadrous, Mina, Takhar, Pam, Chan, Kelvin K W, On Behalf Of The CanREValue Collaboration

“…The CanREValue Collaboration established the Reassessment & Uptake Working Group to develop a preliminary process to reassess funded cancer drugs in Canada. A…”
Get full text

Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline by Cheng, Susanna, Evans, William K, Stys-Norman, Denise, Shepherd, Frances A

“…This clinical practice guideline, based on a systematic review, evaluates chemotherapy options for patients with relapsed small cell lung cancer (SCLC)…”
Get more information

Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals by Fitzgerald, Natalie R, Flanagan, William M, Evans, William K, Miller, Anthony B

“…Objectives: The study aimed to incorporate an estimate of risk for asbestos exposure in the Canadian Cancer Risk Management Lung Cancer (CRMM-LC)…”
Get full text

Prognostic Implications of Treatment Delays in the Surgical Resection of Lung Cancer by Evans, William K., MD, FRCPC

“…The survival of patients with lung cancer remains low in most developed countries, which is largely attributable to the advanced stage of the disease when it…”
Get full text

Influence of Sex on Toxicity and Treatment Outcome in Small-Cell Lung Cancer by SINGH, Simron, PARULEKAR, Wendy, MURRAY, Nevin, FELD, Ronald, EVANS, William K, DONGSHENG TU, SHEPHERD, Frances A

“…Female sex has been shown consistently to be a favorable prognostic factor in small-cell lung cancer (SCLC). Studies have shown that women with other tumor…”
Get full text

Evidence-Based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada by EVANS, William K, LAUPACIS, Andreas, GULENCHYN, Karen Y, LEVIN, Les, LEVINE, Mark

“…The uptake of new health care technologies is usually driven by industry promotion, physician interest, patient demand, and institutional ability to acquire…”
Get full text

Ignoring the Obvious: Smoking Cessation Improves Survival by Evans, William K, Warren, Graham W, Dresler, Carolyn

Get more information

Breathing Life Into Lung Cancer Screening Trials by Dresler, Carolyn M, Evans, William K

Get more information

Job stress and job satisfaction of cancer care workers by Grunfeld, Eva, Zitzelsberger, Louise, Coristine, Marjorie, Whelan, Timothy J., Aspelund, Faye, Evans, William K.

“…Background: There is an increasing demand for oncology care as a result of a number of trends. In combination with ongoing changes to the health‐care system,…”
Get full text

Sociodemographic characteristics associated with thyroid cancer risk in Canada by Bushnik, Tracey, Evans, William K

“…Thyroid cancer incidence in Canada has increased rapidly over the past 25 years. This study examines thyroid cancer incidence and relative risk according to…”
Get full text